A high‐precision view of intercompartmental drug transport via simultaneous, seconds‐resolved, in situ measurements in the vein and brain

• Published in: British journal of pharmacology Vol. 181; no. 20; pp. 3869 - 3885
• Main Authors: Gerson, Julian, Erdal, Murat Kaan, Dauphin‐Ducharme, Philippe, Idili, Andrea, Hespanha, Joao P., Plaxco, Kevin W., Kippin, Tod E.
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01-10-2024
• Subjects: Aptamers; Blood levels; blood–brain‐barrier; blood–CSF–barrier; Cerebrospinal fluid; compartmental models; drug transport; Jugular vein; Mathematical models; Pharmacokinetics; Vancomycin; Veins & arteries; Ventricles (cerebral); drug transport; blood–brain‐barrier; blood–CSF–barrier; compartmental models
• ISSN: 0007-1188; 1476-5381; 1476-5381
• DOI: 10.1111/bph.16471

Background and Purpose
The ability to measure specific molecules at multiple sites within the body simultaneously, and with a time resolution of seconds, could greatly advance our understanding of drug transport and elimination.
Experimental Approach
As a proof‐of‐principle demonstration, here we describe the use of electrochemical aptamer‐based (EAB) sensors to measure transport of the antibiotic vancomycin from the plasma (measured in the jugular vein) to the cerebrospinal fluid (measured in the lateral ventricle) of live rats with temporal resolution of a few seconds.
Key Results
In our first efforts, we made measurements solely in the ventricle. Doing so we find that, although the collection of hundreds of concentration values over a single drug lifetime enables high‐precision estimates of the parameters describing intracranial transport, due to a mathematical equivalence, the data produce two divergent descriptions of the drug's plasma pharmacokinetics that fit the in‐brain observations equally well. The simultaneous collection of intravenous measurements, however, resolves this ambiguity, enabling high‐precision (typically of ±5 to ±20% at 95% confidence levels) estimates of the key pharmacokinetic parameters describing transport from the blood to the cerebrospinal fluid in individual animals.
Conclusions and Implications
The availability of simultaneous, high‐density ‘in‐vein’ (plasma) and ‘in‐brain’ (cerebrospinal fluid) measurements provides unique opportunities to explore the assumptions almost universally employed in earlier compartmental models of drug transport, allowing the quantitative assessment of, for example, the pharmacokinetic effects of physiological processes such as the bulk transport of the drug out of the CNS via the dural venous sinuses.